|

Prasugrel 5 mg Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 4: 2

Top Sponsors

  • University of Florida1
  • J.P.S Henriques1

Indications

  • Heart Disease2
  • Percutaneous Coronary Intervention (PCI)1
  • Coronary Arterial Disease (CAD)1
  • Coronary Artery Disease1

Other1 trial

Prasugrel Monotherapy Reduced Dose in Acute and Chronic Coronary Syndrome Patients After Percutaneous Coronary Intervention (PROMOTE)
Phase 4

Jacksonville, Florida1 trial

Comparison of Dual Antiplatelet Therapy De-escalation by Dose Reduction Versus Switching in Patients Undergoing PCI: The Switching Antiplatelet-8 (SWAP-8) Study

University of Florida

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.